In this regard, MT2A protein exerts its anti-cancer effects through inactivation of NFKBIA (NFKB Inhibitor Alpha) subsequent binding to MZF1 (Myeloid Zinc Finger 1) [9, 10]. This evidence concerns the gene MT2A and cancer.